Literature DB >> 22889754

Functional priorities in daily life for children and young people with dystonic movement disorders and their families.

Hortensia Gimeno1, Anne Gordon, Kylee Tustin, Jean-Pierre Lin.   

Abstract

PURPOSE: This study aims to describe the most prevalent functional concerns of a group of young people with dystonia and their primary carers, and to explore the relationship between concerns, aetiology, severity of motor disability and manual ability.
METHOD: The Canadian Occupational Performance Measure (COPM) was completed with 57 children with dystonic movement disorders (65% males/35% females, mean 11.2 years (3.5-18.1)): 25% had primary dystonia, 75% secondary dystonia. Gross motor and manual function were classified using the Gross Motor Function Classification System (GMFCS) and the Manual Ability Classification System (MACS). COPM concerns were analysed with respect to aetiology and severity of motor disability.
RESULTS: Almost three quarters of the respondents were GMFCS/MACS IV-V. All respondents had at least one concern around self-care. Other concerns included access to assistive technology, pain, dressing activities, use of tools and social participation. The nature and presence of concerns did not statistically differ according to the severity of gross motor or manual function impairment, though qualitative differences were noted. No statistical difference was found in relation to aetiology.
INTERPRETATION: Children and young people with dystonia have common functional concerns and priorities independent of the cause of dystonia, gross motor severity or manual function ability.
Copyright © 2012 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22889754     DOI: 10.1016/j.ejpn.2012.07.007

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  7 in total

1.  Characteristics of bilateral hand function in individuals with unilateral dystonia due to perinatal stroke: sensory and motor aspects.

Authors:  Ana Carolina de Campos; Sahana N Kukke; Mark Hallett; Katharine E Alter; Diane L Damiano
Journal:  J Child Neurol       Date:  2014-01-05       Impact factor: 1.987

2.  The Relative Merits of an Individualized Versus a Generic Approach to Rating Functional Performance in Childhood Dystonia.

Authors:  Hortensia Gimeno; Jessica Farber; Jessica Thornton; Helene Polatajko
Journal:  Children (Basel)       Date:  2020-12-25

3.  Occupational performance of children with autism spectrum disorder and quality of life of their mothers.

Authors:  Seyedeh Zeinab Beheshti; Seyed-Sirvan Hosseini; Saman Maroufizadeh; Amir Almasi-Hashiani
Journal:  BMC Res Notes       Date:  2022-01-15

Review 4.  Dystonia Management: What to Expect From the Future? The Perspectives of Patients and Clinicians Within DystoniaNet Europe.

Authors:  Marenka Smit; Alberto Albanese; Monika Benson; Mark J Edwards; Holm Graessner; Michael Hutchinson; Robert Jech; Joachim K Krauss; Francesca Morgante; Belen Pérez Dueñas; Richard B Reilly; Michele Tinazzi; Maria Fiorella Contarino; Marina A J Tijssen
Journal:  Front Neurol       Date:  2021-06-03       Impact factor: 4.003

5.  Amelioration of Muscle and Nerve Pathology in LAMA2 Muscular Dystrophy by AAV9-Mini-Agrin.

Authors:  Chunping Qiao; Yi Dai; Viktoriya D Nikolova; Quan Jin; Jianbin Li; Bin Xiao; Juan Li; Sheryl S Moy; Xiao Xiao
Journal:  Mol Ther Methods Clin Dev       Date:  2018-01-31       Impact factor: 6.698

6.  Protocol: Using Single-Case Experimental Design to Evaluate Whole-Body Dynamic Seating on Activity, Participation, and Quality of Life in Dystonic Cerebral Palsy.

Authors:  Hortensia Gimeno; Tim Adlam
Journal:  Healthcare (Basel)       Date:  2019-12-31

7.  Application of Machine Learning Using Decision Trees for Prognosis of Deep Brain Stimulation of Globus Pallidus Internus for Children With Dystonia.

Authors:  Syed Ahmar Shah; Peter Brown; Hortensia Gimeno; Jean-Pierre Lin; Verity M McClelland
Journal:  Front Neurol       Date:  2020-08-14       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.